The heart-liver metabolic axis: Defective communication exacerbates disease

EMBO Molecular Medicine

Volumn 6, Issue 4, 2014, Pages 436-438

  Baskin, Kedryn K ^a   Bookout, Angie L ^a   Olson, Eric N ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NATRIURETIC FACTOR;

ARTICLE; DISEASE EXACERBATION; ENERGY METABOLISM; FATTY ACID TRANSPORT; HEART MUSCLE METABOLISM; HOMEOSTASIS; HYPERTROPHIC CARDIOMYOPATHY; LIPID LIVER LEVEL; LIVER FUNCTION; LIVER METABOLISM; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; SARCOMERE; SKELETAL MUSCLE; WHITE ADIPOSE TISSUE; ANIMAL; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FEMALE; HEART MUSCLE; LIVER; MALE; METABOLISM;

ANIMALS; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; FEMALE; LIVER; MALE; MYOCARDIUM;

EID: 84898600335     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.1002/emmm.201303800     Document Type: Article

References (16)

1. Bhatia LS, Curzen NP, Calder PC, Byrne CD (2012) Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur Heart J 33: 1190-1200
2. Blad CC, Tang C, Offermanns S (2012) G protein-coupled receptors for energy metabolites as new therapeutic targets. Nat Rev Drug Discov 11: 603-619
3. de Bold AJ (2011) Thirty years of research on atrial natriuretic factor: historical background and emerging concepts. Can J Physiol Pharmacol 89: 527-531
4. Bordicchia M, Liu D, Amri EZ, Ailhaud G, Dessi-Fulgheri P, Zhang C, Takahashi N, Sarzani R, Collins S (2012) Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J Clin Invest 122: 1022-1036
5. Bryzgalova G, Lundholm L, Portwood N, Gustafsson JA, Khan A, Efendic S, Dahlman-Wright K (2008) Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice. Am J Physiol Endocrinol Metab 295: E904-E912
6. Crilley JG, Boehm EA, Blair E, Rajagopalan B, Blamire AM, Styles P, McKenna WJ, Ostman-Smith I, Clarke K, Watkins H (2003) Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. J Am Coll Cardiol 41: 1776-1782
7. D'Eon TM, Souza SC, Aronovitz M, Obin MS, Fried SK, Greenberg AS (2005) Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem 280: 35983-35991
8. Grueter CE, van Rooij E, Johnson BA, DeLeon SM, Sutherland LB, Qi X, Gautron L, Elmquist JK, Bassel-Duby R, Olson EN (2012) A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell 149: 671-683
9. Liu S, Brown JD, Stanya KJ, Homan E, Leidl M, Inouye K, Bhargava P, Gangl MR, Dai L, Hatano B et al (2013) A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use. Nature 502: 550-554
10. Maass A, Leinwand LA (2000) Animal models of hypertrophic cardiomyopathy. Curr Opin Cardiol 15: 189-196
11. Magida JA, Leinwand LA (2014) Metabolic crosstalk between the heart and liver impacts familial hypertrophic cardiomyopathy. EMBO Mol Med 6: 482-495
12. Maron BJ, Maron MS (2013) Hypertrophic cardiomyopathy. Lancet 381: 242-255
13. Rashed HM, Nair BG, Patel TB (1992) Regulation of hepatic glycolysis and gluconeogenesis by atrial natriuretic peptide. Arch Biochem Biophys 298: 640-645
14. Roberts LD, Bostrom P, O'Sullivan JF, Schinzel RT, Lewis GD, Dejam A, Lee YK, Palma MJ, Calhoun S, Georgiadi A et al (2014) Beta-Aminoisobutyric Acid Induces Browning of White Fat and Hepatic beta-Oxidation and Is Inversely Correlated with Cardiometabolic Risk Factors. Cell Metab 19: 96-108
15. Seidman CE, Seidman JG (2011) Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history. Circ Res 108: 743-750
16. Wang L, Seidman JG, Seidman CE (2010) Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy. Ann Intern Med 152: 513-520, W181